Tickers

1. Composite Trajectory Verdict

Given KO's asset-light concentrate model with significant equity-method bottler income, the income statement carries the most weight for assessing operating performance, though cash flow conversion and balance-sheet liability management (especially the IRS tax litigation exposure) are critical supplementary lenses.

Composite Trajectory: Mixed

The 2025 income statement shows a sharp recovery from 2024: operating income rose 38% to $13.8B and net income attributable to shareowners rose 23% to $13.1B (10-K 2025-12-31, Consolidated Statements of Operations). However, 2024 itself was a down year versus 2023 (operating income fell 12% to $10.0B). Operating cash flow remains well below its 2023 peak of $11.6B, at $7.4B in 2025 versus $6.8B in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The balance sheet strengthened on the equity side (shareowners' equity rose to $32.2B from $24.9B) but added $5.3B of assets held for sale (Africa bottling operations) and carries a disclosed potential $14B incremental tax liability for 2010–2025 (10-K 2025-12-31, MD&A – Liquidity, Capital Resources and Financial Position). Quarterly data from the 10-Qs is not provided in the filings, so intra-year trends cannot be assessed.

2. Red Flags

• Operating cash flow collapse in 2024 with only partial recovery: Net cash from operations fell from $11.6B (2023) to $6.8B (2024) and reached $7.4B in 2025, still 36% below the 2023 level (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Recurring “non-recurring” other operating charges: Other operating charges were $1.3B (2025), $4.2B (2024), $2.0B (2023), driven by repeated trademark impairments (BodyArmor $960M in 2025, $760M in 2024), fairlife contingent consideration remeasurements ($3.1B in 2024, $47M in 2025), and productivity program costs (10-K 2025-12-31, MD&A – Other Operating Charges).
• Large and growing tax litigation exposure: The Company paid a $6.0B IRS deposit for 2007–2009 and estimates a potential $14B incremental liability for 2010–2025 (10-K 2025-12-31, MD&A – Liquidity, Capital Resources and Financial Position).
• Assets held for sale surged to $5.3B from $131M, reflecting the classification of Africa bottling operations, with an associated $1.3B impairment charge recorded in other income (10-K 2025-12-31, Note 2 – Assets and Liabilities Held for Sale).
• Goodwill declined $2.6B to $15.5B, primarily from the Africa held-for-sale reclassification (10-K 2025-12-31, Note 7 – Goodwill).
• Trade accounts receivable factoring program shrinking: Factored receivables fell from $21.9B (2024) to $14.7B (2025), reducing a source of operating cash flow (10-K 2025-12-31, MD&A – Liquidity, Capital Resources and Financial Position).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Net operating revenues grew modestly for three consecutive years: $45.8B (2023) → $47.1B (2024) → $47.9B (2025) (10-K 2025-12-31, Consolidated Statements of Operations). Gross margin expanded each year: 59.5% → 61.1% → 61.6% (calculated from revenue and cost of goods sold). Operating income, however, swung from $11.3B (2023) down to $10.0B (2024) then up to $13.8B (2025), the 2025 jump driven largely by a $2.9B reduction in other operating charges (from $4.2B to $1.3B). Net income attributable to shareowners followed a similar pattern: $10.7B → $10.6B → $13.1B. Diluted EPS rose from $2.47 (2024) to $3.04 (2025) after being flat at $2.46–$2.47 in 2023–2024. Concentrate sales volume grew 1% in 2025; unit case volume was flat (10-K 2025-12-31, MD&A – Beverage Volume). Price/mix contributed +4% to revenue in 2025, offset by -2% currency and -1% acquisitions/divestitures (10-K 2025-12-31, MD&A – Net Operating Revenues).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Operating cash flow dropped sharply from $11.6B (2023) to $6.8B (2024), then recovered to $7.4B (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). The 2024 decline was attributed to the $6.0B IRS tax deposit, higher working capital outflows, and loss of factoring benefits; the 2025 improvement reflected strong cash operating results, lower tax payments, and a $6.1B fairlife milestone payment outflow (10-K 2025-12-31, MD&A – Cash Flows from Operating Activities). Investing activities swung from +$2.5B (2024) to -$67M (2025), mainly due to lower proceeds from investment disposals ($4.7B vs $6.6B) and continued $2.1B capex (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing outflows increased to $8.1B (2025) from $6.9B (2024), driven by higher dividends ($8.8B vs $8.4B) and a $1.3B noncontrolling interest sale inflow partially offsetting share repurchases ($746M vs $1.8B) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow minus capex) was approximately $5.3B in 2025, $4.7B in 2024, and $9.7B in 2023.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 4% to $104.8B (2025) from $100.5B (2024) (10-K 2025-12-31, Consolidated Balance Sheets). Current assets rose 19% to $31.0B, led by a $5.2B increase in assets held for sale (Africa bottling operations) and higher short-term investments ($3.6B vs $2.0B), while cash declined slightly to $10.3B from $10.8B. Long-term debt was essentially flat at $42.1B vs $42.4B. Current maturities of long-term debt jumped to $1.8B from $648M. Shareowners' equity increased 29% to $32.2B from $24.9B, boosted by $13.1B net income, $2.7B other comprehensive income (primarily $2.9B currency translation gains), and a $1.3B noncontrolling interest sale, partially offset by $8.8B dividends and $634M share repurchases (10-K 2025-12-31, Consolidated Statements of Shareowners' Equity). Noncontrolling interest equity rose to $2.1B from $1.5B. The contingent consideration liability for fairlife ($6.1B at end-2024) was paid in March 2025 (10-K 2025-12-31, Note 8).

6. Data Gaps

• Quarterly revenue, operating income, and cash flow trends for 2025 and 2026 (the four 10-Q filings are listed but their financial statement data is not provided in the document set).
• Segment-level operating income and margins for quarterly periods to assess intra-year trajectory.
• Detailed breakdown of the $7.2B net change in operating assets and liabilities in 2025 cash flow statement (only aggregate shown).
• Projected 2026 effective tax rate impact of the One Big Beautiful Bill Act (OBBBA) beyond management's statement that it "did not materially impact" 2025 and is not expected to materially impact 2026 (10-K 2025-12-31, MD&A – Income Taxes).
• Resolution timeline and cash impact of the IRS tax litigation appeal (Eleventh Circuit briefing completed August 2025, decision pending) (10-K 2025-12-31, MD&A – Liquidity, Capital Resources and Financial Position).